Geron Historical Balance Sheet

GERN Stock

USD 1.42 0.03 2.16%

Trend analysis of Geron balance sheet accounts such as Other Current Liabilities of 81.6 M or Total Current Liabilities of 92.7 M provides information on Geron's total assets, liabilities, and equity, which is the actual value of Geron to its prevalent stockholders. By breaking down trends over time using Geron balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Geron latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Geron is a good buy for the upcoming year.

Geron Inventory

40.65 Million

Build AI portfolio with Geron Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

About Geron Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Geron at a specified time, usually calculated after every quarter, six months, or one year. Geron Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Geron and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Geron currently owns. An asset can also be divided into two categories, current and non-current.

Geron Balance Sheet Chart

At this time, Geron's Non Currrent Assets Other are very stable compared to the past year. As of the 26th of April 2025, Cash And Short Term Investments is likely to grow to about 426.9 M, while Short and Long Term Debt Total is likely to drop about 3.1 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Short Term Debt

Add Fundamental

Total Assets

Total assets refers to the total amount of Geron assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Geron books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Geron balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Geron are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Geron's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Geron current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.At this time, Geron's Non Currrent Assets Other are very stable compared to the past year. As of the 26th of April 2025, Cash And Short Term Investments is likely to grow to about 426.9 M, while Short and Long Term Debt Total is likely to drop about 3.1 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	55.8M	85.9M	3.2M	3.1M
Total Assets	190.6M	394.1M	593.8M	623.5M

Short Long Term Debt Total Total Assets

Geron balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Net Receivables	Common Stock	Other Assets	Long Term Debt	Common Stock Total Equity
Total Assets		0.21	0.93	0.83	0.92	0.65	-0.53	-0.84	0.72	0.7	0.07	0.47	0.99	0.95	0.93	0.2	0.9	0.96	0.73	1.0	0.25	0.88	0.45	0.93	0.87	0.88
Short Long Term Debt Total	0.21		0.39	0.61	0.18	0.5	0.59	-0.44	0.56	0.52	0.54	0.67	0.31	0.44	0.01	0.17	0.39	0.22	0.47	0.23	0.84	-0.16	0.21	0.24	0.1	0.53
Other Current Liab	0.93	0.39		0.91	0.76	0.73	-0.4	-0.86	0.85	0.78	-0.01	0.66	0.93	0.97	0.9	0.29	0.88	0.97	0.76	0.94	0.37	0.83	0.4	0.89	0.88	0.94
Total Current Liabilities	0.83	0.61	0.91		0.69	0.69	-0.25	-0.83	0.82	0.9	0.12	0.69	0.88	0.93	0.71	0.3	0.83	0.86	0.68	0.86	0.66	0.62	0.4	0.84	0.7	0.9
Total Stockholder Equity	0.92	0.18	0.76	0.69		0.48	-0.39	-0.79	0.54	0.53	0.32	0.34	0.93	0.83	0.75	0.02	0.86	0.78	0.66	0.91	0.25	0.71	0.55	0.82	0.67	0.77
Property Plant And Equipment Net	0.65	0.5	0.73	0.69	0.48		-0.1	-0.44	0.61	0.61	0.1	0.4	0.64	0.69	0.66	0.53	0.48	0.71	0.84	0.65	0.36	0.54	-0.04	0.72	0.75	0.6
Net Debt	-0.53	0.59	-0.4	-0.25	-0.39	-0.1		0.26	-0.11	-0.34	0.62	0.23	-0.45	-0.37	-0.67	-0.08	-0.33	-0.57	-0.01	-0.53	0.33	-0.79	-0.13	-0.53	-0.54	-0.22
Retained Earnings	-0.84	-0.44	-0.86	-0.83	-0.79	-0.44	0.26		-0.74	-0.73	-0.16	-0.6	-0.89	-0.91	-0.7	0.17	-0.99	-0.79	-0.54	-0.85	-0.41	-0.62	-0.79	-0.73	-0.6	-0.94
Accounts Payable	0.72	0.56	0.85	0.82	0.54	0.61	-0.11	-0.74		0.69	0.14	0.87	0.74	0.82	0.7	0.28	0.73	0.79	0.69	0.73	0.38	0.58	0.36	0.62	0.69	0.89
Cash	0.7	0.52	0.78	0.9	0.53	0.61	-0.34	-0.73	0.69		-0.04	0.5	0.75	0.81	0.62	0.32	0.7	0.76	0.47	0.73	0.62	0.56	0.34	0.75	0.59	0.76
Non Current Assets Total	0.07	0.54	-0.01	0.12	0.32	0.1	0.62	-0.16	0.14	-0.04		0.35	0.12	0.08	-0.21	-0.15	0.17	-0.12	0.4	0.03	0.33	-0.33	0.24	-0.07	-0.18	0.19
Non Currrent Assets Other	0.47	0.67	0.66	0.69	0.34	0.4	0.23	-0.6	0.87	0.5	0.35		0.51	0.61	0.4	0.23	0.57	0.52	0.6	0.47	0.45	0.26	0.27	0.34	0.47	0.77
Cash And Short Term Investments	0.99	0.31	0.93	0.88	0.93	0.64	-0.45	-0.89	0.74	0.75	0.12	0.51		0.97	0.88	0.15	0.93	0.94	0.71	0.99	0.36	0.82	0.52	0.92	0.82	0.91
Common Stock Shares Outstanding	0.95	0.44	0.97	0.93	0.83	0.69	-0.37	-0.91	0.82	0.81	0.08	0.61	0.97		0.86	0.2	0.94	0.95	0.72	0.96	0.46	0.79	0.5	0.92	0.82	0.96
Non Current Liabilities Total	0.93	0.01	0.9	0.71	0.75	0.66	-0.67	-0.7	0.7	0.62	-0.21	0.4	0.88	0.86		0.29	0.76	0.97	0.67	0.92	0.01	0.98	0.28	0.87	0.95	0.79
Other Current Assets	0.2	0.17	0.29	0.3	0.02	0.53	-0.08	0.17	0.28	0.32	-0.15	0.23	0.15	0.2	0.29		-0.13	0.31	0.43	0.2	0.26	0.28	-0.7	0.37	0.48	0.09
Other Stockholder Equity	0.9	0.39	0.88	0.83	0.86	0.48	-0.33	-0.99	0.73	0.7	0.17	0.57	0.93	0.94	0.76	-0.13		0.84	0.58	0.91	0.37	0.69	0.76	0.79	0.66	0.94
Total Liab	0.96	0.22	0.97	0.86	0.78	0.71	-0.57	-0.79	0.79	0.76	-0.12	0.52	0.94	0.95	0.97	0.31	0.84		0.72	0.96	0.23	0.92	0.34	0.92	0.93	0.88
Property Plant And Equipment Gross	0.73	0.47	0.76	0.68	0.66	0.84	-0.01	-0.54	0.69	0.47	0.4	0.6	0.71	0.72	0.67	0.43	0.58	0.72		0.71	0.28	0.54	0.09	0.68	0.75	0.71
Total Current Assets	1.0	0.23	0.94	0.86	0.91	0.65	-0.53	-0.85	0.73	0.73	0.03	0.47	0.99	0.96	0.92	0.2	0.91	0.96	0.71		0.29	0.88	0.46	0.94	0.87	0.89
Short Term Debt	0.25	0.84	0.37	0.66	0.25	0.36	0.33	-0.41	0.38	0.62	0.33	0.45	0.36	0.46	0.01	0.26	0.37	0.23	0.28	0.29		-0.09	0.17	0.41	0.05	0.44
Net Receivables	0.88	-0.16	0.83	0.62	0.71	0.54	-0.79	-0.62	0.58	0.56	-0.33	0.26	0.82	0.79	0.98	0.28	0.69	0.92	0.54	0.88	-0.09		0.24	0.84	0.91	0.68
Common Stock	0.45	0.21	0.4	0.4	0.55	-0.04	-0.13	-0.79	0.36	0.34	0.24	0.27	0.52	0.5	0.28	-0.7	0.76	0.34	0.09	0.46	0.17	0.24		0.29	0.08	0.58
Other Assets	0.93	0.24	0.89	0.84	0.82	0.72	-0.53	-0.73	0.62	0.75	-0.07	0.34	0.92	0.92	0.87	0.37	0.79	0.92	0.68	0.94	0.41	0.84	0.29		0.83	0.77
Long Term Debt	0.87	0.1	0.88	0.7	0.67	0.75	-0.54	-0.6	0.69	0.59	-0.18	0.47	0.82	0.82	0.95	0.48	0.66	0.93	0.75	0.87	0.05	0.91	0.08	0.83		0.75
Common Stock Total Equity	0.88	0.53	0.94	0.9	0.77	0.6	-0.22	-0.94	0.89	0.76	0.19	0.77	0.91	0.96	0.79	0.09	0.94	0.88	0.71	0.89	0.44	0.68	0.58	0.77	0.75

Click cells to compare fundamentals

Geron Account Relationship Matchups

Geron balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	270.7M	226.0M	190.6M	394.1M	593.8M	623.5M
Short Long Term Debt Total	29.7M	55.0M	55.8M	85.9M	3.2M	3.1M
Other Current Liab	22.3M	37.0M	44.6M	54.1M	77.8M	81.6M
Total Current Liabilities	30.9M	45.5M	76.7M	108.1M	88.3M	92.7M
Total Stockholder Equity	210.9M	126.4M	80.0M	247.9M	280.3M	294.3M
Property Plant And Equipment Net	658K	5.4M	793K	4.7M	4.2M	4.4M
Net Debt	19.4M	20.1M	(1.5M)	15.9M	(75.8M)	(72.0M)
Retained Earnings	(1.2B)	(1.3B)	(1.4B)	(1.6B)	(1.8B)	(1.7B)
Accounts Payable	6.9M	6.7M	10.2M	6.2M	8.6M	9.0M
Cash	10.3M	34.9M	57.2M	70.0M	79.0M	42.1M
Non Current Assets Total	70.9M	38.8M	10.3M	52.7M	4.2M	4.0M
Non Currrent Assets Other	6.8M	4.8M	9.5M	4.7M	4.1M	4.5M
Cash And Short Term Investments	196.6M	183.7M	173.1M	333.7M	406.6M	426.9M
Common Stock Shares Outstanding	271.5M	327.6M	380.8M	570.6M	646.0M	678.3M
Liabilities And Stockholders Equity	270.7M	226.0M	190.6M	394.1M	593.8M	623.5M
Non Current Liabilities Total	28.8M	54.1M	33.9M	38.1M	225.2M	236.4M
Other Current Assets	2.9M	1.7M	4.4M	6.0M	6.9M	3.8M
Other Stockholder Equity	1.4B	1.4B	1.5B	1.8B	2.1B	2.2B
Total Liab	59.8M	99.6M	110.6M	146.1M	313.5M	329.1M
Property Plant And Equipment Gross	6.0M	6.0M	793K	6.0M	5.9M	6.2M
Total Current Assets	199.9M	187.2M	180.2M	341.3M	491.0M	515.5M
Accumulated Other Comprehensive Income	78K	(173K)	(219K)	185K	212.8K	223.4K
Short Term Debt	1.8M	1.8M	21.9M	47.8M	1.9M	1.9M
Net Receivables	722K	1.8M	3.1M	1.7M	38.8M	40.7M
Common Stock	310K	324K	390K	545K	606K	636.3K
Other Assets	1.5M	4.8M	5.4M	98.6M	113.4M	119.1M
Common Stock Total Equity	200K	310K	324K	390K	448.5K	470.9K
Short Term Investments	186.4M	148.9M	115.9M	263.7M	327.6M	343.9M
Property Plant Equipment	408K	658K	650K	793K	713.7K	1.4M
Inventory	(802K)	(722K)	(1.4M)	(3.1M)	38.7M	40.6M
Net Tangible Assets	137.4M	210.9M	126.4M	80.0M	92.0M	139.7M
Retained Earnings Total Equity	(1.1B)	(1.2B)	(1.3B)	(1.4B)	(1.3B)	(1.3B)
Capital Surpluse	1.2B	1.4B	1.4B	1.5B	1.7B	1.3B
Long Term Investments	63.4M	28.7M	0.0	43.3M	94.5M	99.2M
Net Invested Capital	235.0M	176.2M	131.2M	329.9M	398.8M	232.1M
Net Working Capital	168.9M	141.7M	103.6M	233.3M	402.7M	422.8M

Pair Trading with Geron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Geron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will appreciate offsetting losses from the drop in the long position's value.

Moving together with Geron Stock

0.86	VKTX	Viking Therapeutics	Pair Corr
0.86	ELEV	Elevation Oncology	Pair Corr
0.92	XFOR	X4 Pharmaceuticals	Pair Corr

Moving against Geron Stock

0.39	JNJ	Johnson Johnson	Pair Corr
0.36	VALN	Valneva SE ADR	Pair Corr

The ability to find closely correlated positions to Geron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Geron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Geron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Geron to buy it.

The correlation of Geron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Geron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Geron moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Geron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:

How To Invest In Geron

Details

Is Geron Stock a good investment?

Details

What is Geron's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.27)

Revenue Per Share

0.119

Quarterly Revenue Growth

2.1 K

Return On Assets

(0.22)

Return On Equity

(0.66)

The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Geron Historical Balance Sheet

Geron Inventory

40.65 Million

About Geron Balance Sheet Analysis

Geron Balance Sheet Chart

Total Assets

Total Current Liabilities

Geron balance sheet Correlations

Geron Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Geron balance sheet Accounts

Pair Trading with Geron

Moving together with Geron Stock

Moving against Geron Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Cash And Short Term Investments
Net Receivables	+ 0.98	Non Current Liabilities Total
Common Stock Shares Outstanding	+ 0.97	Other Current Liab
Total Liab	+ 0.97	Other Current Liab

Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Total Equity	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.91	Retained Earnings
Cash And Short Term Investments	- 0.89	Retained Earnings
Retained Earnings	- 0.86	Other Current Liab
Total Current Assets	- 0.85	Retained Earnings